Monday, November 11, 1996
By Eric Pierce
The biotech market, after four consecutive weeks of falling prices, was not ignored in last week's equity buying after the Republicans kept control of the House and Senate. The BioCentury 100 was up 1 percent on the week, despite a sluggish performance from the large cap stocks, excepting Biogen (BGEN). The election news prompted investors to push up the Dow Jones Industrials to a record 6219.82, up 3 percent on the week. The NASDAQ Composite also rose 3 percent, while the S&P 500 added 4 percent.